2025年的商用车行业，在激烈的市场竞争中，悄然经历了一场涉及范围广、影响深远的高 层人事"换防"。 据第一商用车网不完全统计，从2025年初到年尾，包括一汽解放、中国重汽、东风公司、 潍柴动力、福田汽车、江淮汽车、北奔重汽、金龙汽车和中通客车等在内的主流商用车企 业，相继完成了董事长、总经理等核心决策岗位的调整。下面，就让我们一起回顾下这些重 要时刻。 一汽解放：新任董事长与营销一把手履新 2025年1月15日，一汽解放发生工商变更，吴碧磊卸任法定代表人、董事长，由李胜接 任。 7月1日，一汽解放营销体系迎来重要人事调整，于广江出任营销总部总经理、党委书记， 全面统筹解放公司的销售服务、客户运营、渠道建设及品牌营销工作。 中国重汽：全年多轮调整，新一届领导班子正式亮相 2025年1月9日，中国重汽集团济南卡车股份有限公司发布第九届董事会第五次会议决议公 告。经与会董事充分讨论后，审议并表决通过刘洪勇担任公司董事长和公司法人 3月27日，中国重汽集团发布执行董事、总裁及授权代表变动及董事委员会人士变动公告。 公告显示，王琛已辞任执行董事、执行委员会成员、战略及投资委员会成员、总裁及授权代 表职务，刘正涛已获委 ...

证券代码：600841 900920 证券简称：动力新科 动力B股 公告编号：临2025-080 上海新动力汽车科技股份有限公司2025年第二次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本次会议是否有否决议案：无 一、会议召开和出席情况 (四)表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 本次股东会所采用的表决方式是现场投票和网络投票相结合的方式。 （1）现场会议召开的日期时间：2025年12月19日下午3：00。召开地点：上海新动力汽车科技股份有限 公司（上海市杨浦区军工路2636 号）办公大楼会议室。 （2）网络投票系统：上海证券交易所股东会网络投票系统。 网络投票起止时间：自2025年12月19日至2025年12月19日。采用上海证券交易所网络投票系统，通过交 易系统投票平台的投票时间为股东会召开当日的交易时间段，即9:15-9:25,9:30-11:30，13:00-15:00；通 过互联网投票平台的投票时间为股东会召开当日的9:15-15:00。 本次 ...

证券日报网讯 12月19日晚间，动力新科发布公告称，公司2025年第二次临时股东会审议通过《关于补 选公司董事的议案》等多项议案。 （文章来源：证券日报） ...

在股东交流环节中，动力新科管理层对股东们关心的问题进行了交流。动力新科表示，上汽红岩重整获 得法院裁定批准后，动力新科自2025年12月起将不再合并上汽红岩报表，动力新科和上汽红岩都将踏上 新征程，重新再出发。 谈及未来，动力新科总经理刘建超表示，公司将继续以发动机业务为基础，积极拓展产品型谱，优化产 品结构，积极推进天然气、甲醇、氨等多种燃料发动机的研发及配套，加快提升动力电池、电驱桥等新 能源业务销量，积极探索新兴业务，寻求公司第二增长曲线；展望"十五五"，公司将继续坚持"平台 化、智能网联化、新能源化、国际化"的发展战略，继续坚持以市场为导向、以用户为中心，积极开 拓，勇于创新，培育差异化竞争优势，着力打造一个品牌更有影响力、体系更具竞争力、体制机制更灵 活的"新动力"，力争到"十五五"末销量、收入双倍增。 中证报中证网讯(记者乔翔)动力新科（600841）12月19日晚公告，公司2025年第二次临时股东会于12月 19日召开，会议审议通过了《关于补选公司董事的议案》《关于部分募投项目结项、取消及调整部分募 集资金用途的议案》等多项议案。 ...

（原标题：动力新科：计划"十五五"时期实现销量、收入双倍增） 在当天股东交流环节中，动力新科主要领导对股东们关心的问题作了交流。谈及未来，公司总经理刘建 超指出，公司将继续以发动机业务为基础，积极拓展产品型谱，优化产品结构，积极推进天燃气、甲 醇、氨等多种燃料发动机的研发及配套，加快提升动力电池、电驱桥等新能源业务销量，积极探索新兴 业务，寻求公司第二增长曲线；展望"十五五"时期，公司将继续坚持"平台化、智能网联化、新能源 化、国际化"的发展战略，继续坚持以市场为导向、以用户为中心，积极开拓、勇于创新，培育差异化 竞争优势，着力打造一个品牌更有影响力、体系更具竞争力、体制机制更灵活的"新动力"，力争到"十 五五"时期末实现销量、收入双倍增。 根据第一商用车网披露的相关数据，2025年1—11月份，动力新科的发动机销售15.8万台，同比增速为 22.39%，排名行业第二。市场预计动力新科2025年全年销量将处在其历史较高水平。（厉平） 动力新科(600841)12月19日晚间公告，公司2025年第二次临时股东会顺利召开，各项议案均高票通过。 此前，上汽红岩重整获得法院裁定批准，动力新科自2025年12月起将不再 ...

重要内容提示： 证券代码：600841 900920 证券简称：动力新科 动力 B 股 公告编号：临 2025-080 上海新动力汽车科技股份有限公司 2025年第二次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一) 股东会召开的时间：2025 年 12 月 19 日 (二) 股东会召开的地点：上海新动力汽车科技股份有限公司办公大楼会议室 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 357 | | --- | --- | | 其中：A 股股东人数 | 343 | | 境内上市外资股股东人数（B 股） | 14 | | 2、出席会议的股东所持有表决权的股份总数（股） | 722,346,204 | | 其中：A 股股东持有股份总数 | 721,784,010 | | 境内上市外资股股东持有股份总数(B 股) | 562,194 | | 3、出席会议的股东所持有表决权股份数占公司有表决 ...

上海市金茂律师事务所 致:上海新动力汽车科技股份有限公司 (引言) 上海新动力汽车科技股份有限公司(以下简称"公司")2025年第二次临 时股东会（以下简称"本次股东会"）现场会议于 2025 年 12 月 19 日在上海新 动力汽车科技股份有限公司(上海市杨浦区军工路 2636 号) 办公大楼会议室召 开。上海市金茂律师事务所经公司聘请委派沈粤律师、路遥律师(以下简称"本 所律师")出席会议,就本次股东会的召集、召开程序,出席会议人员资格,会 议议案,以及会议的表决程序、表决结果等发表法律意见。 本法律意见书根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规 则》(以下简称"《股东会规则》")、《上海证券交易所上市公司自律监管指 引第 1 号 -- 规范运作（2025 年 5 月修订）》（以下简称"《自律监管指引 1 号》")等有关法律、法规和规范性文件以及《上海新动力汽车科技股份有限公 司章程》（以下简称"《公司章程》"）而出具。 为出具本法律意见书,本所审查了公司本次股东会的有关文件和材料。本所 得到公司如下保证,即其已提供了 ...

Core Viewpoint - SAIC Hongyan's restructuring plan has been approved by the Chongqing Fifth Intermediate People's Court, marking a significant step towards its operational recovery and debt resolution [1][3]. Group 1: Restructuring Process - On July 1, 2025, Chongqing Anji Hongyan Logistics filed for bankruptcy restructuring for SAIC Hongyan due to its inability to repay debts and severe insolvency, despite having restructuring value [1]. - The court appointed Taihe Tai (Chongqing) Law Firm and Xinyong Zhonghe Accounting Firm as the managers for the restructuring process [1]. - A public recruitment for restructuring investors was initiated to facilitate the restructuring efforts [1]. Group 2: Investment and Financial Implications - On September 29, 2025, the board of Dongli Xinke approved a joint investment of 6.66 billion yuan to participate in SAIC Hongyan's restructuring, aiming for a 14.66% stake post-restructuring [2]. - The total investment from the consortium is expected to reach 30 billion yuan, targeting a 66% stake in SAIC Hongyan after restructuring [2]. - The restructuring plan was approved by creditors on December 10, 2025, indicating a consensus on the proposed recovery strategy [2]. Group 3: Operational Strategy and Market Position - The court found that the restructuring plan aligns with the principles of fair repayment and maximization of creditor interests, with a higher debt repayment rate compared to liquidation [3]. - The operational strategy includes leveraging SAIC Hongyan's complete heavy truck production line and advanced technology, focusing on both domestic and international markets while enhancing the "Hongyan" brand [3]. - SAIC Hongyan's strong market presence in the dump truck sector and opportunities in the export and new energy markets are highlighted as key advantages for future growth [4]. Group 4: Impact on Dongli Xinke - Following the restructuring approval, Dongli Xinke will adjust its financial statements to exclude SAIC Hongyan, which is expected to positively impact its financial metrics for 2025 [4]. - The one-time gain from this adjustment is projected to represent approximately 150% to 180% of Dongli Xinke's net profit attributable to the parent company for 2024 [4].

Group 1 - The core announcement is that Shanghai New Power Automotive Technology Co., Ltd. (referred to as "New Power") has received a court ruling approving the restructuring plan of its wholly-owned subsidiary, SAIC Hongyan Automobile Co., Ltd. (referred to as "SAIC Hongyan"), which will terminate the company's restructuring process [1] - The restructuring plan was previously approved by the creditors in a second meeting, indicating broad recognition of the plan's rationality and feasibility, showcasing confidence in SAIC Hongyan's future development [1] - The approval of the restructuring plan allows SAIC Hongyan to enter the implementation phase, which is expected to systematically resolve historical debt issues and optimize the company's equity structure [1] Group 2 - Following the restructuring, New Power's equity interest in SAIC Hongyan will be adjusted to zero, and starting from December 2025, SAIC Hongyan's financial statements will no longer be included in New Power's consolidated financial statements [2] - The one-time equity disposal gain from this adjustment is estimated to account for approximately 150%-180% of New Power's audited net profit attributable to shareholders for the fiscal year 2024, with specific figures to be confirmed by the audited financial statements [2] - Analysts suggest that the exclusion of SAIC Hongyan from the consolidated scope will have a positive impact, allowing New Power to operate with a lighter burden moving forward [2]

Group 1 - Shouyao Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries regarding the specifics of the listing [1] - Jiangsu Guoxin's subsidiary, Guoxin Mazhou, has completed the trial operation of a 1000MW coal-fired power unit, which is set to officially commence operations on December 12, 2025 [2] - Yuekang Pharmaceutical's mRNA tumor vaccine has received clinical trial approval from the National Medical Products Administration for treating advanced solid tumors [3] Group 2 - Dongli New Science plans to invest 666 million yuan in the restructuring of SAIC Hongyan, acquiring approximately 14.66% equity post-restructuring [4] - Longsheng Technology is set to invest approximately 350 million yuan in the establishment of an intelligent robot innovation center in Wuxi [5] - Shangwei Co. has received a government subsidy of 2.212 million yuan, which accounts for 13.53% of its audited net profit for 2024 [6] Group 3 - Anglikang has received drug registration certificates for Diclofenac Sodium Enteric-Coated Tablets and approval for a supplemental application for Sacubitril/Valsartan Sodium Tablets [7] - Guangzhou Development has received acceptance notices for the registration of 8 billion yuan in medium-term notes and 6 billion yuan in short-term financing bonds [8] - Kebo Da plans to increase capital by 21.2 million euros (approximately 174 million yuan) in its wholly-owned subsidiary in Germany [9][10] Group 4 - Changguang Huaxin has received a total of 11.6672 million yuan in government subsidies, including 8.0552 million yuan related to income [11] - Haizheng Pharmaceutical's subsidiary has received a European Pharmacopoeia suitability certificate for its raw material [12] - Qianjin Pharmaceutical's subsidiary has received a drug registration certificate for Lurasidone Hydrochloride Tablets, used for treating schizophrenia [13] Group 5 - Daimai Co. has received a warning letter from the Shanghai Securities Regulatory Bureau due to failure to timely disclose a significant event related to a fire incident [14] - ST Changyao's subsidiary has recently ceased production due to financial difficulties and competitive pressures in the photovoltaic industry [15] - Guodian Power is investing in the construction of a 2×1000MW expansion project at the Ganbi Power Plant, with a total dynamic investment of 7.218 billion yuan [16] Group 6 - Kaichuang International's subsidiary has completed the handover of a tuna purse seine vessel, expected to be operational by 2026 [16] - Tieke Rail plans to sign an energy management agreement for a distributed photovoltaic project, which is expected to save approximately 1.441 million yuan in electricity costs over 25 years [18] - Bailian Co. plans to sign a land compensation agreement with Friendship Logistics, with a total compensation of 103 million yuan [19] Group 7 - Dayu Water-saving's subsidiary has been pre-awarded two high-standard farmland construction projects, with total expected amounts of 137 million yuan and 135 million yuan respectively [20] - Tianma Technology reported a total eel output of approximately 1197.15 tons in November, with sales prices ranging from 53,000 yuan/ton to 89,000 yuan/ton [21] - Guorui Technology's subsidiary has been shortlisted for the GXLF project with a bid of 76 million yuan [22] Group 8 - Qingdao Food's deputy general manager has resigned for personal reasons [23] - Guosheng Zhike plans to use up to 900 million yuan of idle funds for cash management [24] - Guodian Nanrui plans to use up to 23 billion yuan of idle funds for entrusted wealth management [25] Group 9 - Jiahuan Energy plans to merge its wholly-owned subsidiary, Zhejiang Jiahuan Hydrogen Peroxide Co., Ltd., through an overall absorption merger [26] - Ganyue Expressway reported vehicle toll service revenue of 309 million yuan for November [27] - Jinling Hotel's chairman has resigned due to work changes [28] Group 10 - Lisheng Pharmaceutical's subsidiary has received drug registration certificates for Apremilast Tablets [29] - Baotai has received a positive opinion from the European Medicines Agency for Gotenfia® for various inflammatory conditions [30] - ST Zhisheng has been awarded a smart city governance project with a bid amount of 104 million yuan [31] Group 11 - Chenxi Aviation and its related personnel have received administrative regulatory measures from the Shaanxi Securities Regulatory Bureau due to financial reporting issues [32] - Portong Medical has appointed Xia Canglan as the new deputy general manager [33] - Maide Medical plans to repurchase shares with a total amount between 20 million and 40 million yuan [34] Group 12 - Jimin Health plans to establish a joint venture with a total investment of 600 million yuan, focusing on AI and software development [35] - Beilu Pharmaceutical has received a drug registration certificate for Pioglitazone Metformin Tablets [36] - Hainan Mining plans to entrust the overall management of the Shiluo Iron Mine to a construction company for three years, with a total contract amount of approximately 818 million yuan [38] Group 13 - Huiyu Pharmaceutical has received a drug registration certificate for Nicardipine Hydrochloride Injection [39] - Baoland has received a government subsidy of 10 million yuan related to income [40] - Qingdao Port has terminated the acquisition of 100% equity in an oil company and 50% equity in Rizhao Shihua due to regulatory concerns [41]